LH - Company ID 0000920148
The table below shows LABORATORY CORP OF AMERICA HOLDINGS's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B |
| Cost of revenue | $9.94B | $9.38B | $8.80B | $8.15B | $8.14B | $9.03B |
| Gross profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B | $4.95B |
| R&D | - | - | - | - | - | - |
| SG&A |
LABORATORY CORP OF AMERICA HOLDINGS reported annual revenue of $13.95B for fiscal year 2025. That is up 7.2% from $13.01B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.55B (FY 2016) to $13.95B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.22B |
| $2.23B |
| $2.02B |
| $1.76B |
| $1.69B |
| $1.73B |
| Operating income | $1.38B | $1.09B | $725.60M | $1.44B | $3.05B | $2.45B |
| Income tax | $229.80M | $212.40M | $188.50M | $233.90M | $690.00M | $662.10M |
| Net income | $877.00M | $746.00M | $418.00M | $1.28B | $2.38B | $1.56B |
| EPS (diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 | $15.88 |